Tag: pooled clustered regularly interspaced short palindromic repeats (crispr) screening market size

  • Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market CAGR Forecast Through 2030: Key Trends Shaping Industry Expansion

    Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market CAGR Forecast Through 2030: Key Trends Shaping Industry Expansion

    Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

    Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Size Outlook: How Quickly Will Revenue Expand Through 2030?

    The pooled clustered regularly interspaced short palindromic repeats (crispr) screening market size has experienced significant expansion recently. Its value is projected to rise from $1.3 billion in 2025 to $1.51 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 15.9%. This past growth can be attributed to an increasing need for functional genomics, wider adoption of CRISPR-Cas9 technology, an increase in pharmaceutical research and development, progress in gene editing tools, and the expansion of academic research programs.

    The pooled clustered regularly interspaced short palindromic repeats (crispr) screening market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $2.74 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 16.1%. Factors contributing to this growth during the forecast period include AI-enabled gene screening, the integration of cloud-based genomics platforms, increasing demand for personalized medicine applications, the expansion of biotech infrastructure, and advancements in automation for high-throughput screening. Key trends identified for the forecast period encompass high-throughput screening techniques, the integration of multi-omics data, automated CRISPR workflows, AI-driven gene target identification, and real-time functional genomics analysis.

    Get A Free Sample Report With In-Depth Market Insights:

    https://thebusinessresearchcompany.com/sample_request?id=20824759&type=smp&name=Pooled%20Clustered%20Regularly%20Interspaced%20Short%20Palindromic%20Repeats%20%28CRISPR%29%20Screening%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Growth Factors: What’s Supporting Expansion?

    The growing occurrence of genetic disorders is anticipated to fuel the expansion of the pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market. These conditions, stemming from inherited or acquired DNA irregularities impacting normal bodily functions, are seeing an uptick in prevalence. This increase is partly due to factors such as older parental age, enhanced diagnostic tools, and broader genetic screening efforts, which collectively lead to more cases being identified and reported. Pooled CRISPR screening is vital for genetic disorder research, facilitating high-throughput, genome-wide discovery of genes and pathways linked to diseases. For instance, the Cystic Fibrosis Trust, a UK-based charity, noted in October 2024 that cystic fibrosis patient registrations increased from approximately 11,148 in 2022 to 11,318 in 2023, showing an annual growth of about 1.5%. Consequently, the rising incidence of genetic disorders is a key driver for the pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market.

    Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Segment Analysis Spotlighting Growth Areas

    The pooled clustered regularly interspaced short palindromic repeats (crispr) screening market covered in this report is segmented –

    1) By Screening Type: Genome Wide Screening, Targeted Screening

    2) By Product Type: Libraries, Reagents And Kits, Instruments, Software, Services

    3) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Cas9 Screening, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Interference Screening, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Activation Screening

    4) By Application: Functional Genomics, Drug Discovery, Cancer Research, Gene Regulation, Other Applications

    5) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations, Other End-Users

    Subsegments:

    1) By Genome Wide Screening: Knockout Screening, Activation Screening, Interference Screening

    2) By Targeted Screening: Gene Specific Knockout, Gene Specific Activation, Gene Specific Interference

    Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Industry Trends: What’s Reshaping Demand?

    Major companies in the pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market are concentrating on developing innovative solutions like transcriptome-wide profiling to enable high-throughput functional genomics and precise identification of gene targets for therapeutic and research applications. Transcriptome-wide profiling refers to the comprehensive analysis of all RNA transcripts expressed in a cell or tissue at a given time, providing insights into gene activity, regulation, and cellular functions. For instance, in June 2023, Parse Biosciences Inc., a US-based biotechnology company, launched CRISPR Detect, a technology enabling high-scale single-cell pooled CRISPR screens. This innovation integrates with the company’s Evercode Whole Transcriptome platform to pair individual gene perturbations, via Cas12-based single guide ribonucleic acid (RNA) (sgRNAs), with whole-transcriptome expression profiles across up to one million cells per experiment, overcoming prior throughput and cost barriers in droplet-based single-cell RNA-seq. It expands applications in genome-scale gene function analysis, regulatory networks, signaling pathways, and drug discovery beyond targeted validation.

    Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Key Participants And Competitive Landscape

    Major companies operating in the pooled clustered regularly interspaced short palindromic repeats (crispr) screening market are Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Applied Biological Materials Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., QIAGEN N.V., GenScript Biotech Corporation, Twist Bioscience Corporation, Ginkgo Bioworks Inc., Element Biosciences Inc., Synthego Corporation, Bit.bio Limited, Bioneer Corporation, VectorBuilder Inc., Admera Health LLC, Addgene Inc., Creative Biogene Inc., Cellecta Inc., Vivlion Inc., GeneCopoeia Inc.

    View The Full Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Report:

    https://thebusinessresearchcompany.com/report/pooled-clustered-regularly-interspaced-short-palindromic-repeats-crispr-screening-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

    Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Geographic Analysis: Where Is Demand Rising Fastest?

    North America was the largest region in the pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pooled clustered regularly interspaced short palindromic repeats (crispr) screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Reach Out To Our Team:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas: +1 310-496-7795

    Asia: +44 7882 955267 & +91 8897263534

    Europe: +44 7882 955267

    Email us at: marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Outlook Through 2030 Featuring Market Trends And Industry Developments

    Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Outlook Through 2030 Featuring Market Trends And Industry Developments

    The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

    What Is The Projected Increase In Market Value Of The Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market During 2026–2030?

    The pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market size has seen rapid expansion in recent years. Its valuation is expected to increase from $1.3 billion in 2025 to $1.51 billion in 2026, achieving a compound annual growth rate (CAGR) of 15.9%. This historical development can be attributed to several factors including a growing need for functional genomics, increased uptake of CRISPR-Cas9 technology, advancements in pharmaceutical research and development, progress in gene editing tools, and the proliferation of academic research endeavors.

    The pooled clustered regularly interspaced short palindromic repeats (crispr) screening market size is expected to experience rapid growth in the next few years, projected to reach $2.74 billion by 2030, at a compound annual growth rate (CAGR) of 16.1%. This expansion during the forecast period is attributed to AI-enabled gene screening, the integration with cloud-based genomics platforms, increasing demand for personalized medicine applications, the expansion of biotech infrastructure, and automation in high-throughput screening. Major trends for this period include high-throughput screening techniques, integration with multi-omics data, automated crispr workflows, AI-driven gene target identification, and real-time functional genomics analysis.

    Access Your Free Sample Report For In-Depth Market Analysis:

    https://www.thebusinessresearchcompany.com/sample_request?id=56373934&type=smp&name=Pooled%20Clustered%20Regularly%20Interspaced%20Short%20Palindromic%20Repeats%20%28CRISPR%29%20Screening%20Market%20Report%202026

    What Major Factors Are Driving The Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Forward?

    The growing incidence of genetic conditions is anticipated to fuel expansion within the pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market. Genetic disorders originate from inherited or acquired DNA anomalies, impacting an individual’s normal development, metabolic processes, or physiological function. This increase in prevalence is partly due to factors like older parental age, enhanced diagnostic methods, and broader genetic screening, all contributing to elevated detection and reporting figures. Pooled CRISPR screening is vital for genetic disorder research, facilitating rapid, genome-wide identification of genes and pathways linked to diseases. An example is the Cystic Fibrosis Trust, a UK-based charity, which in October 2024, indicated that 11,148 cystic fibrosis patients were recorded in 2022, rising to 11,318 in 2023, marking an annual increase of approximately 1.5%. Consequently, the increasing occurrence of genetic disorders is boosting the growth of the pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market. Rising Research And Development Investments Driving Growth In The Market Due To Advancements In Real-Time Genomic Data Analysis

    Enhanced research and development funding is anticipated to stimulate the expansion of the pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market in the coming years. R&D investments involve dedicating resources to innovate new products, enhance current offerings, and advance technologies to foster innovation and sustainable business growth. Progressive technological breakthroughs are prompting greater R&D investments, as businesses are compelled to continually innovate and modernize their products and processes to keep pace with swift digital transformation and evolving industry benchmarks. These investments benefit CRISPR screening by facilitating the creation of sophisticated gene-editing instruments, refining protocols, and boosting precision and effectiveness for quicker identification of gene functions. For example, in 2023, the Office for National Statistics, a UK-based government body, reported that the UK government’s net expenditure on R&D climbed to £17.4 billion ($22.1 billion) in 2023, an increase from £16.1 billion ($20.45 billion) in 2022, indicating an 8.2% growth. Thus, the escalating research and development investments are a key factor in driving the growth of the pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market.

    How Is The Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Segmented Across Different Segment Categories?

    The pooled clustered regularly interspaced short palindromic repeats (crispr) screening market covered in this report is segmented –

    1) By Screening Type: Genome Wide Screening, Targeted Screening

    2) By Product Type: Libraries, Reagents And Kits, Instruments, Software, Services

    3) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Cas9 Screening, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Interference Screening, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Activation Screening

    4) By Application: Functional Genomics, Drug Discovery, Cancer Research, Gene Regulation, Other Applications

    5) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations, Other End-Users

    Subsegments:

    1) By Genome Wide Screening: Knockout Screening, Activation Screening, Interference Screening

    2) By Targeted Screening: Gene Specific Knockout, Gene Specific Activation, Gene Specific Interference

    Which Trends Are Impacting The Progress Of The Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market?

    Major companies operating in the pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market are actively developing innovative solutions like transcriptome-wide profiling to enable efficient high-throughput functional genomics and precise identification of gene targets for therapeutic and research applications. Transcriptome-wide profiling refers to the comprehensive analysis of all RNA transcripts expressed in a cell or tissue at a given time, providing valuable insights into gene activity, regulation, and cellular functions. As an illustration, in June 2023, Parse Biosciences Inc., a US-based biotechnology company, launched CRISPR Detect, a technology designed to facilitate high-scale single-cell pooled CRISPR screens. This innovation integrates with the company’s Evercode Whole Transcriptome platform to pair individual gene perturbations, using Cas12-based single guide ribonucleic acid (RNA) (sgRNAs), with whole-transcriptome expression profiles across up to one million cells per experiment, thereby overcoming previous throughput and cost barriers in droplet-based single-cell RNA-seq. This significantly broadens applications in genome-scale gene function analysis, regulatory networks, signaling pathways, and drug discovery, extending beyond targeted validation.

    Which Organizations Play A Role In The Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Landscape?

    Major companies operating in the pooled clustered regularly interspaced short palindromic repeats (crispr) screening market are Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Applied Biological Materials Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., QIAGEN N.V., GenScript Biotech Corporation, Twist Bioscience Corporation, Ginkgo Bioworks Inc., Element Biosciences Inc., Synthego Corporation, Bit.bio Limited, Bioneer Corporation, VectorBuilder Inc., Admera Health LLC, Addgene Inc., Creative Biogene Inc., Cellecta Inc., Vivlion Inc., GeneCopoeia Inc.

    Get The Full Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Report:

    https://www.thebusinessresearchcompany.com/report/pooled-clustered-regularly-interspaced-short-palindromic-repeats-crispr-screening-market-report

    Which Region Dominates The Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market By Market Share?

    North America was the largest region in the pooled clustered regularly interspaced short palindromic repeats (CRISPR) screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pooled clustered regularly interspaced short palindromic repeats (crispr) screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Request A Customized Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market Report For Competitive Insights:

    https://www.thebusinessresearchcompany.com/Customise?id=56373934&name=Pooled%20Clustered%20Regularly%20Interspaced%20Short%20Palindromic%20Repeats%20%28CRISPR%29%20Screening%20Market%20Report%202026&type=smp

    Browse Through More Reports Similar to the Global Pooled Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening Market 2026, By The Business Research Company

    adeno-associated virus (avv) vectors in gene therapy market report 2026

    https://www.thebusinessresearchcompany.com/report/adeno-associated-virus-avv-vectors-in-gene-therapy-global-market-report

    gastric cancer therapy market report 2026

    https://www.thebusinessresearchcompany.com/report/gastric-cancer-therapy-global-market-report

    over the counter (otc) drugs market report 2026

    https://www.thebusinessresearchcompany.com/report/over-the-counter-otc-drugs-global-market-report

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 310-496-7795

    Asia +44 7882 955267 & +91 8897263534

    Europe +44 7882 955267

    Email us at marketing@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model